News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

31

2023

-

07

Improve quality and reduce costs to expand the market and work together to forge ahead | Keyuan Pharmaceutical & Linuo Pharmaceutical held a semi-annual work meeting!

Classification:

News


11

From July 28th to 29th, Shandong Keyuan Pharmaceutical Co., Ltd. and Shandong Linuo Pharmaceutical Co., Ltd. held the 2023 semi-annual policy supervision work meeting to review and summarize the experience and achievements in the first half of the year, deploy key tasks in the second half of the year, and mobilize all cadres and employees to take responsibility for the direction Forge ahead under pressure, anchor the goals and tasks for the second half of the year, gather strength to make breakthroughs, and scale new heights.

Lun Lijun, chairman of Keyuan Pharmaceutical and Linuo Pharmaceutical, Jiang Hongsheng, general manager of Keyuan Pharmaceutical and Linuo Pharmaceutical, and the company's management team attended the meeting.

11

11

At this conference, Keyuan Pharmaceutical specially invited Professor Dai Ting from the Business School of Jinan University to give lectures. Professor Dai made a detailed discussion on the excellent performance and quality management of enterprises, and explained in simple terms from the aspects of corporate strategy formulation, market strategic goal formulation, market strategy formulation, action plan, key performance indicators and resource requirements. This quality management training has deepened the understanding of quality management for all employees, improved the business level of the company in promoting product and service quality, accelerated brand building, strengthened risk awareness, and provided a solid foundation for the high-quality development of Keyuan Pharmaceuticals. strength.

 

11

11

At the meeting, the functional departments of Keyuan Pharmaceutical and Linuo Pharmaceutical respectively made orderly reports from the aspects of marketing, technology research and development, quality management, project management, intelligent manufacturing and functional guarantee. Summarized the work in the first half of the year, combined with its own actual situation, focused on the precise arrangement of the goals, tasks and ideas and measures for the second half of the year, carried out targeted work, ensured that various measures were implemented and effectively implemented, and promoted Keyuan Pharmaceutical and Linuo Pharmaceutical The annual mission objectives were fully achieved.

 

11

11

Jiang Hongsheng, general manager of Keyuan Pharmaceutical and Linuo Pharmaceutical, summarized the work in the first half of 2023. He said that in the first half of 2023, the company will deepen reforms, continuously improve the driving force of management, adhere to the focus of internal and external resources, and strengthen quality management measures. The half-year is a stage of decisive victory that is related to the work of the whole year and connects the past with the next. Jiang Hongsheng carefully analyzed the new situation and changes that the company faced in the first half of the year, and required all cadres and employees to stick to their goals and tasks, strive for progress amidst changes, and dare to challenge without fear. Encourage the management team to strengthen the team building of various departments, strengthen the in-depth communication and integration between Keyuan Pharmaceutical and Linuo Pharmaceutical, strengthen the improvement of the advantages of "integration of raw materials and preparations", and take more targeted combat measures for the annual performance target to ensure the overall year target achieved.

11

Lun Lijun, chairman of Keyuan Pharmaceutical and Linuo Pharmaceutical, gave instructions that research and development is the leader, and quality is the guarantee. Regardless of Keyuan Pharmaceutical or Linuo Pharmaceutical, safe production is a curse. Without safety, everything is zero, and we must ensure safety. Under the premise of fine quality. All Keyuan Pharmaceuticals and Linuo Pharmaceuticals must have the spirit of facing difficulties without shrinking, resolving conflicts and not dodging, and implement more vigorous breakthroughs in various tasks, so as to promote the work of Keyuan Pharmaceuticals and Linuo Pharmaceuticals to reach new heights steps.

The career can only be done brilliantly, and there is no glory waiting for it. All cadres and employees of Keyuan Pharmaceutical and Linuo Pharmaceutical have established the struggle concept of "man can conquer nature", keep in mind their responsibilities and fulfill their missions. People are the cornerstone of enterprise development. In the future, Keyuan Pharmaceutical and Linuo Pharmaceutical will take mission indicators as military orders and difficult problems as batons to take responsibility for moving forward, reshaping development, and climbing the peak again, and will continue to excel in the new situation with excellent results. Stride the road of high-quality development.

11

Related news

The central media theme communication event went to Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical!

The central media theme communication event went to Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical!

2023-08-31

On August 29, the "Central Media High-Quality Development Theme Communication Activity" participated by more than ten media including People's Daily, Xinhua News Agency, Guangming Daily, etc., visited Shandong Keyuan Pharmaceutical Co., Ltd.

Solidly promote the

Solidly promote the "Quality Month" activities to help quality work reach a new level | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a Quality Month Knowledge Competition!

2023-08-30

Quality is the core competitiveness related to the survival of an enterprise. Strengthening the construction of a quality enterprise is an effective measure for Keyuan Pharmaceutical (stock code: 301281.SZ) to implement the concept of "lean production and quality first". The company continues to improve the quality system and strengthen training.

Empower quality management and improve quality efficiency | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a QC group training meeting

Empower quality management and improve quality efficiency | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a QC group training meeting

2023-08-24

In order to thoroughly implement the theme spirit of "Quality is in my hands and customers are in my heart" for Keyuan Pharmaceutical (stock code: 301281.SZ) Quality Month in 2023, and empower and improve quality management, the Quality Management Center and Human Resources Center held a meeting on August 23 The joint organization carried out a one-day QC group activity training meeting.

Start from the heart and embark on a new journey together | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held an employee theme birthday party and the third cooking competition awards event

Start from the heart and embark on a new journey together | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held an employee theme birthday party and the third cooking competition awards event

2023-08-23

In order to better carry forward the corporate culture spirit of family, one table meal, one heart, one effort, enhance the cohesion and sense of belonging of all employees, enrich the spiritual and cultural life of employees, and let the majority of employees feel that Keyuan Pharmaceutical (stock code: 301281.SZ) The warmth of the big family.